Pablo G. Legorreta

CEO, Chairman of the Board at Royalty Pharma · 6 reported transactions in 2 companies · latest report Aug 5, 2026

Their trades

Aug 5, 2026 · RPRX

65,216

Feb 11, 2026 · RPRX

157,828

Nov 5, 2025 · RPRX

36,559

Aug 6, 2025 · RPRX

21,901

Jun 3, 2025 · PROK

3,823,996

Jun 3, 2025 · PROK

3,823,996

6 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

CEO, Chairman of the Board at Royalty Pharma · 6 reported transactions in 2 companies · latest report Aug 5, 2026